packageNeratinib

neratinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Neratinib is a HER2-blocking kinase inhibitor used to treat breast cancer. It is an approved medicine, with one product authorised in the European Union for breast cancer.

Summary written by glm-5.3-flash from Wikidata Q6995920 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:neratinib
ATC codes:L01EH02
DrugBank:DB11828
PubChem CID:9915743
ChEBI:61397
Wikidata:Q6995920
formula:C30H29ClN6O3
molar mass:557.051 g/mol (PubChem CID 9915743)
logP:4.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown